In the Phase III ICONIC-LEAD trial, 75% of adolescents with moderate-to-severe plaque psoriasis treated with icotrokinra achieved completely clear skin by week 24. Results from the Phase III ...

84.1% of adolescents on icotrokinra achieved clear/almost clear skin at Week 16 vs ... came about through a partnership with Johnson & Johnson JNJ. Data at the 2025 World Congress of Pediatric ...